News for 'Therapeutic Goods Administration'

Pune Firm Unveils Diabetes-Control Implant

Pune Firm Unveils Diabetes-Control Implant

Rediff.com19 Nov 2025

This innovation works by stimulating our natural organs so that it can produce and maintain the insulin balance.

Aussie regulator probes Ranbaxy

Aussie regulator probes Ranbaxy

Rediff.com4 Mar 2009

Australian health regulator Therapeutic Goods Administration is investigating Indian pharma major Ranbaxy, following US allegations of the company falsifying data and test results of new drug applications, a media report says.

Ranbaxy gets Australia nod for antipsychotic drug

Ranbaxy gets Australia nod for antipsychotic drug

Rediff.com25 Mar 2009

Drug major Ranbaxy on Wednesday said it has received approval from the Australian health regulator to market its antipsychotic drug Ozidal Risperidone in that country.

How safe are Indian herbal medicines?

How safe are Indian herbal medicines?

Rediff.com2 Apr 2007

Australia has joined the UK, USA and Canada in warning its citizens against using unapproved traditional medicines from India and China.

Nigeria flags 2 India-made drugs as substandard, having toxins

Nigeria flags 2 India-made drugs as substandard, having toxins

Rediff.com20 Jun 2023

Oral paracetamol and another cough medicine manufactured by companies based in Mumbai and Punjab were found to be "sub-standard or found to be containing toxins", reports Sohini Das.

Indian pharma cos get a shot in the arm in $12-bn Australian drug market

Indian pharma cos get a shot in the arm in $12-bn Australian drug market

Rediff.com29 Apr 2022

Indian drug firms get a shot in the arm in the $12 bn Australian drug market as the Therapeutic Goods Administration (TGA), Australia agrees to accelerate the drug approval process in that country for Indian players who already have an approved plant and product from one of the stringent regulatory authorities like US, EU or Canada. From current sales of $340 mn, the Indian firms can see a significant upside in sales; felt Dinesh Dua, former chairman of the Pharmaceutical Exports Promotion Council of India (Pharmexcil), and the MD of Nectar Lifesciences. He highlighted that only 12 percent of the Australian drug market is generic, as against 80-90 per cent in the US or EU. Of this $1.5 bn generic drug market in India, Indian companies have a small share.

WHO issues alert against syrup by Indian manufacturer

WHO issues alert against syrup by Indian manufacturer

Rediff.com25 Apr 2023

The WHO on Tuesday issued a product alert over contaminated syrup by an Indian manufacturer, warning that it is unsafe for use, especially in children, and may result in serious injury or death.

Australia to ease travel restrictions from December 1

Australia to ease travel restrictions from December 1

Rediff.com22 Nov 2021

From December 1, fully vaccinated eligible visa holders including students and skilled workers, can come to Australia without needing to apply for a travel exemption, a statement by the Australian government said.

COVAX urges equal recognition of WHO approved vaccines

COVAX urges equal recognition of WHO approved vaccines

Rediff.com2 Jul 2021

Calling for 'equal recognition of vaccines', COVAX on Thursday urged all governments to recognise as 'fully vaccinated' those people who have received COVID-19 vaccines deemed safe by World Health Organisation, saying any move that restricts travel of people based on the vaccines they have received is 'counter-effective, both in spirit and outcome'.

Australia formally recognises India's Covaxin

Australia formally recognises India's Covaxin

Rediff.com1 Nov 2021

Australia's medicines and medical devices regulator on Monday formally recognised India's Covaxin, a vaccine against the coronavirus as the country's border was reopened for the first time in nearly 20 months.

Hydroxychloroquine doesn't help treat COVID-19: Report

Hydroxychloroquine doesn't help treat COVID-19: Report

Rediff.com22 Apr 2020

Trump has been aggressively promoting the use of hydroxychloroquine in the treatment of COVID-19 patients.

2017 begins with a bang for outbound M&A deals

2017 begins with a bang for outbound M&A deals

Rediff.com31 Jan 2017

Indian companies have made acquisitions of $1 billion so far in January

'Won't be forgotten': Trump thanks India for hydroxychloroquine

'Won't be forgotten': Trump thanks India for hydroxychloroquine

Rediff.com9 Apr 2020

'I want to thank Prime Minister Modi of India for allowing us to have what we requested for the problem arose and he was terrific. We will remember it'

Biological E plans to make 1.5 billion Corbevax jabs in 2021

Biological E plans to make 1.5 billion Corbevax jabs in 2021

Rediff.com2 Jul 2021

By 2022, there is a plan to make an mRNA-technology vaccine, for which it has tied up with Canadian firm Providence Therapeutics.

Covid vaccine possible by 2021 first quarter: Vardhan

Covid vaccine possible by 2021 first quarter: Vardhan

Rediff.com13 Sep 2020

Vardhan stated the government is taking full precautions in human trials of vaccines and the National Expert Group on Vaccine Administration for COVID-19 under the chairmanship of Dr V K Paul, member-health, NITI Aayog, is drawing up a detailed strategy on how to immunize the majority of the population.

8 Tips to Get Rid of a Headache

8 Tips to Get Rid of a Headache

Rediff.com30 Mar 2021

Missing meals, eating at odd times, and other poor dietary practices are all tell-tale causes of that dull, throbbing sensation in your head, says nutritionist and wellness coach Pooja Bhargava.

Quality perceptions hobble Jan Aushadi drugs

Quality perceptions hobble Jan Aushadi drugs

Rediff.com10 Oct 2018

Large pharmaceutical firms feel that if the quality parameters and assurance levels are brought up to the level of branded generics, then Jan Aushadhi medicines would find it difficult to retain their affordability.

10 TIPS to achieve your FITNESS goals

10 TIPS to achieve your FITNESS goals

Rediff.com16 Mar 2021

Embrace a daily sport. Cook and eat your meals with love. Ditch the pills. Hydrate well.

ICMR aims to launch COVID-19 vaccine by Aug 15

ICMR aims to launch COVID-19 vaccine by Aug 15

Rediff.com3 Jul 2020

The vaccine candidate, ZyCoV-D, showed a "strong immune response" in animal studies, and the antibodies produced were able to completely neutralise the wild type virus, Zydus said. The 12 institutes have been asked by the ICMR to fast track clinical trials of the vaccine as it is being considered as one of the top priority projects which are being monitored at the topmost level of the government.

'Talent is everywhere and relevant to a nation's success'

'Talent is everywhere and relevant to a nation's success'

Rediff.com9 Jul 2020

'Everybody says 5G and communication is important.' 'Everybody says automation, robotics, human computing interfaces -- people and machines working together -- is the future.' 'Everybody agrees that cybersecurity is something that is here to stay.' 'Everybody agrees that synthetic biology is important.' 'Instead of outlining thinking about industries for tomorrow and the future, let the evolutionary pathway be built in a way that it promotes robust, creative, thinking.'

Dilip Shanghvi's X factor shows up in different ways

Dilip Shanghvi's X factor shows up in different ways

Rediff.com13 Mar 2015

Dilip Shanghvi has never tried to be everything to everybody.

Sun Pharma draws up plan to fix ailing Ranbaxy

Sun Pharma draws up plan to fix ailing Ranbaxy

Rediff.com12 Sep 2014

It hopes to turn around Ranbaxy within four years of closing the deal by improving efficiency and resolving all regulatory issues

The amazing success story of Flipkart's CTO

The amazing success story of Flipkart's CTO

Rediff.com17 Dec 2014

'There was a time when I went without salary for about six months,' says Amod Malviya, an alumnus of IIT Kharagpur and currently CTO, Flipkart.

Full text: What Modi, Obama agreed on

Full text: What Modi, Obama agreed on

Rediff.com25 Jan 2015

This is the joint statement issued by the ministry of external affairs on the visit of US President Barack Obama to India.